Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia (Q43437995)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia |
scientific article |
Statements
1 reference
Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia (English)
1 reference
Hayes M Dansky
1 reference
Daniel Bloomfield
1 reference
Patrice Gibbons
1 reference
Sherry Liu
1 reference
Christine McCrary Sisk
1 reference
Diane Tribble
1 reference
James M McKenney
1 reference
Thomas W Littlejohn
1 reference
Yale Mitchel
1 reference
1 September 2011
1 reference
1 reference
Identifiers
1 reference